{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:15Z","timestamp":1740134895412,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,3]]},"DOI":"10.1182\/blood.2021014629","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T16:35:23Z","timestamp":1643906123000},"page":"647-648","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Waking up CML leukemia stem cells for the kill"],"prefix":"10.1182","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7998-2753","authenticated-orcid":false,"given":"Kaosheng","family":"Lv","sequence":"first","affiliation":[{"name":"Children's Hospital of Philadelphia;"},{"name":"Perelman School of Medicine at the University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-2273","authenticated-orcid":false,"given":"Wei","family":"Tong","sequence":"additional","affiliation":[{"name":"Children's Hospital of Philadelphia;"},{"name":"Perelman School of Medicine at the University of Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"5","key":"2022020316332861100_B1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.2021011802","article-title":"MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common \u03b2 chain cytokine receptor endocytosis","volume":"139","author":"Zhao","year":"2022","journal-title":"Blood."},{"issue":"4","key":"2022020316332861100_B2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and resistance to BCR-ABL1-targeted therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell."},{"issue":"26","key":"2022020316332861100_B3","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.2020004834","article-title":"An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia","volume":"135","author":"Ko","year":"2020","journal-title":"Blood."},{"issue":"10","key":"2022020316332861100_B4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N Engl J Med."},{"issue":"4","key":"2022020316332861100_B5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ccell.2019.08.004","article-title":"Combining the allosteric inhibitor asciminib with ponatinib suppresses emergence of and restores efficacy against highly resistant BCR-ABL1 mutants","volume":"36","author":"Eide","year":"2019","journal-title":"Cancer Cell."},{"issue":"8","key":"2022020316332861100_B6","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41375-019-0512-y","article-title":"Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia","volume":"33","author":"Branford","year":"2019","journal-title":"Leukemia."},{"issue":"1","key":"2022020316332861100_B7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest."},{"issue":"6","key":"2022020316332861100_B8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.cell.2019.08.009","article-title":"Fate mapping via Ms4a3-expression history traces monocyte-derived cells","volume":"178","author":"Liu","year":"2019","journal-title":"Cell."},{"issue":"3","key":"2022020316332861100_B9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.bbrc.2017.12.117","article-title":"Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis","volume":"495","author":"Ishibashi","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"issue":"9","key":"2022020316332861100_B10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.it.2021.07.002","article-title":"The tetraspan MS4A family in homeostasis, immunity, and disease","volume":"42","author":"Mattiola","year":"2021","journal-title":"Trends Immunol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/5\/647\/1866508\/bloodbld2021014629c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/5\/647\/1866508\/bloodbld2021014629c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T16:35:31Z","timestamp":1643906131000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/5\/647\/483724\/Waking-up-CML-leukemia-stem-cells-for-the-kill"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,2,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021014629","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}